News and features
Read the latest news and features about our world-leading research, discoveries, fundraising and philanthropy. If you want to keep updated on our news, you can follow us on social media or sign up for our Search newsletter.
If you’re a journalist and want to find out more, you can contact our media relations team.
Less is more for radiotherapy in early breast cancers
Less is more for radiotherapy in early breast cancers
The Wellcome Trust award £4 million to the ICR
The Institute of Cancer Research, London, has been awarded £4 million from the Wellcome Trust to continue their groundbreaking work developing cancer drugs that inhibit the PARP enzyme tankyrase.
Statement in reaction to the Science and Technology Committee report on clinical trials
The ICR support wider registration and reporting of clinical trials, but explain that a more pressing issue is the burden of EU regulation which is holding up clinical trials to find better cancer treatments.
New research turns cancer’s own weapons against itself
Scientists have discovered a potential new way of treating a type of blood cancer called myeloma that poisons cancer cells with their own secretions.
Advanced scan looks inside tumours to tell if cancer cells have died
A high-tech imaging technique can allow scientists to see into the middle of tumours and tell whether treatments are killing the cancer cells inside, new research reports.
Collagen clue reveals new drug target for untreatable form of lung cancer
Collagen, the stuff of ligaments and skin, and the most abundant protein in the human body, has an extraordinary role in triggering chemical signals that help protect the body from cancer, a new ICR study reveals.
ICR scientists find genes for common childhood leukaemia
The largest study of its kind has linked two inherited genetic variants with an increase in susceptibility to acute lymphoblastic leukaemia.
Researchers reveal new insights into drug resistance in metastatic renal cancer
Responses to treatment among metastatic renal cancers are closely linked with changes in tumour blood vessel supply, finds new research from The Institute of Cancer Research, London.
Highly potent new drug targets cancer cells' DNA repair
A drug which has shown promise in early human trials for cancer could be up to 200 times more potent than others of its type, a study from The Institute of Cancer Research, London, has shown.
New treatments target resistant bowel cancer
Two new drug classes appear to overcome resistance in colorectal cancer cells to one of our built in defences against the disease.
New scan could help in treatment planning for individual patients
A type of non-invasive imaging method could help assess whether cancer patients are likely to respond to radiotherapy, a new study has shown.
Of Ducks and Tumours
